Try a new search

Format these results:

Searched for:

person:wakefj01

in-biosketch:yes

Total Results:

251


The harmful dysfunction model of alcohol use disorder: revised criteria to improve the validity of diagnosis and prevalence estimates

Wakefield, Jerome C; Schmitz, Mark F
AIMS: To formulate harmful-dysfunction (HD) diagnostic criteria for alcohol use disorder (AUD) and test whether they increase validity relative to standard DSM criteria, as evidenced by lowered prevalence, increased validator levels including service use, severity, and family history, and enhanced specificity. DESIGN: DSM-IV AUD, DSM-IV dependence, DSM-5 AUD, and HD AUD definitions were compared on eight validity-related tests using nationally representative community data. SETTING: United States of America PARTICIPANTS: National Epidemiological Survey of Alcoholism and Related Conditions (NESARC) respondents, ages 18-54 (wave 1, N=29,673; wave 2, N=24,444). MEASURES: NESARC DSM-IV and DSM-5 criteria were taken from published studies. Whereas DSM-5 diagnosis requires any two AUD symptoms, HD criteria were constructed from NESARC items to require symptoms of both impaired-control dysfunction (withdrawal, drink to prevent/stop withdrawal, can't stop/reduce drinking, or craving [wave 2 only]) and harm (sacrificed important activities, problems caring for home/family, job/school problems, health problems, psychological problems, or problems with family/friends). Validators included service use, severity, and family history, among others. Specificity was tested using a teen-transient-drinker criterion group. FINDINGS: Compared with DSM-5 AUD (DSM-IV results were similar), HD criteria yielded lower prevalence (95% CIs): HD lifetime 6.7% (6.2%, 7.2%), one-year 2.3% (2.0%, 2.5%); DSM-5 lifetime 38.2% (36.5%, 39.9%), one-year 13.2% (11.7%, 13.1%). HD AUD was higher than DSM-5 on pathology validators, including: lifetime alcohol-related service use: HD 41.0% (38.1%, 43.9%), DSM-5 11.5% (10.7%, 12.3%); severity (number of lifetime alcohol symptoms): HD 20.8 (20.4, 21.2), DSM-5 10.6 (10.4, 10.8); and family history of alcohol problems: HD 50.1% (47.3, 52.9), DSM-5 32.8% (31.6, 34.0). HD criteria eliminated 83% of a DSM-5 teen-transient-drinker false-positives criterion group. CONCLUSIONS: Prevalence of a diagnosis of 'alcohol use disorder' appears to be lower when using 'harmful-dysfunction' diagnostic criteria than using standard DSM criteria, partly by reducing misdiagnosis of teenage transient drinkers
PMID: 25622535
ISSN: 0965-2140
CID: 1447582

DSM-5, psychiatric epidemiology and the false positives problem

Wakefield, J C
The revision effort leading to the publication of the fifth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-5) was flawed in process, goals and outcome. The revision process suffered from lack of an adequate public record of the rationale for changes, thus shortchanging future scholarship. The goals, such as dimensionalising diagnosis, incorporating biomarkers and separating impairment from diagnosis, were ill-considered and mostly abandoned. However, DSM-5's greatest problem, and the target of the most vigorous and sustained criticism, was its failure to take seriously the false positives problem. By expanding diagnosis beyond plausible boundaries in ways inconsistent with DSM-5's own definition of disorder, DSM-5 threatened the validity of psychiatric research, including especially psychiatric epidemiology. I present four examples: increasing the symptom options while decreasing the diagnostic threshold for substance use disorder, elimination of the bereavement exclusion from major depression, allowing verbal arguments as evidence of intermittent explosive disorder and expanding attention-deficit/hyperactivity disorder to adults before addressing its manifest false positives problems.
PMID: 25675983
ISSN: 2045-7960
CID: 1630742

Psychological justice : DSM-5, false positive diagnosis, and fair equality of opportunity

Wakefield, Jerome C
ORIGINAL:0010472
ISSN: 0887-0373
CID: 1901762

La perdita della tristezza : come la psichiatria ha trasformato la tristezza in depressione = [Loss of sadness]

Horwitz, Allan V; Wakefield, Jerome C; Fiori Nastro, Paolo; Pappagallo, Elena; Polese, Daniela
Roma : L'Asino d'Oro, 2015
Extent: XXV, 449 p. ; 21 cm
ISBN: 8864432795
CID: 3799732

Die Psychiatrisierung der Wechselfalle des Lebens : die "DSM-Pharma-Connection"

Chapter by: Wakefield, Jerome C
in: Big Pharma : wie profitgierige Unternehmen unsere Gesundheit aufs Spiel setzen by Borch-Jacobsen, Mikkel; Reuter, Helmut [Eds]
Munchen ; Berlin ; Zurich : Piper, 2015
pp. 246-263
ISBN: 9783492056793
CID: 1901782

The loss of grief : science and pseudoscience in the debate over DSM-5's elimination of the bereavement exclusion

Chapter by: Wakefield, Jerome C
in: The DSM-5 in perspective : philosophical reflections on the psychiatric babel by Demazeux, Steeves; Singy, Patrick [Eds]
Dordrecht : Springer, 2015
pp. 157-178
ISBN: 9789401797658
CID: 1901802

The biostatistical theory versus the harmful dysfunction analysis, part 1: is part-dysfunction a sufficient condition for medical disorder?

Wakefield, Jerome C
Christopher Boorse's biostatistical theory of medical disorder claims that biological part-dysfunction (i.e., failure of an internal mechanism to perform its biological function), a factual criterion, is both necessary and sufficient for disorder. Jerome Wakefield's harmful dysfunction analysis of medical disorder agrees that part-dysfunction is necessary but rejects the sufficiency claim, maintaining that disorder also requires that the part-dysfunction causes harm to the individual, a value criterion. In this paper, I present two considerations against the sufficiency claim. First, I analyze Boorse's central argument for the sufficiency claim, the "pathologist argument," which takes pathologists' intuitions about pathology as determinative of medical disorder and conclude that it begs the question and fails to support the sufficiency claim. Second, I present four counterexamples from the medical literature in which salient part-dysfunctions are considered nondisorders, including healthy disease carriers, HIV-positive status, benign mutations, and situs inversus totalis, thus falsifying the sufficiency claim and supporting the harm criterion.
PMID: 25336733
ISSN: 1744-5019
CID: 1870462

Uncomplicated depression is normal sadness, not depressive disorder: further evidence from the NESARC [Letter]

Wakefield, Jerome C; Schmitz, Mark F
PMCID:4219075
PMID: 25273307
ISSN: 1723-8617
CID: 1283032

Predictive validation of single-episode uncomplicated depression as a benign subtype of unipolar major depression

Wakefield, J C; Schmitz, M F
OBJECTIVE: To evaluate the predictive validity of a proposed benign major depressive disorder (MDD) subtype, single-episode 'uncomplicated MDD', defined as MDD that remits within 6 months and lacks severe impairment, psychotic ideation, suicidal ideation, psychomotor retardation, and feeling worthless. METHOD: Using two-wave National Epidemiologic Survey on Alcohol and Related Conditions data, four groups differing in wave 1 lifetime MDD history (no history [n = 27 609]; single-episode uncomplicated [n = 418]; other single-episode [n = 1943]; multiple episode [n = 2473]) were evaluated for 3-year follow-up rates of major depressive episode (MDE), generalized anxiety disorder (GAD), and suicide attempt. RESULTS: Follow-up rates for no-MDD-history, single-episode uncomplicated MDD, other single-episode MDD, and multiple-episode MDD, respectively, were depressive episode 6.1%, 6.9%, 19.5%, 27.1%; GAD 2.7%, 4.3%, 7.8%, 11.2%; and suicide attempt 0.3%, 0.1%, 0.8%, 1.7%. For all validators, 3-year rates for single-episode uncomplicated cases were not significantly different from no-MDD-history rates, but significantly lower than both single- and multiple-episode other-MDD rates. Mild MDD, defined by having only five or six symptoms, did not yield similarly benign results; logistic regression showed 'uncomplicated' provides incremental validity over 'mild' in explaining validator rates. Validator differences were not explainable by treatment-rate differences. CONCLUSION: Single-episode uncomplicated MDD is a benign subtype lacking typical MDD negative sequelae. The planned DSM-5.1 revision should reinstitute an extended bereavement exclusion applied to all stressors.
PMID: 23952635
ISSN: 0001-690x
CID: 551212

Wittgenstein's nightmare: why the RDoC grid needs a conceptual dimension

Wakefield, Jerome C
PMCID:3918013
PMID: 24497242
ISSN: 1723-8617
CID: 865362